Article
New targets and new mechanisms in lung cancer.
Oncology (Williston Park, N.Y.) - 1 May 2013
Carrizosa Daniel R, Mileham Kathryn F, Haggstrom Daniel E
Abstract excerpt
With the advent of the importance of histology in non-small-cell lung cancer (NSCLC) and the development of targeted agents that work on newly found mutations, the field of lung cancer therapy has greatly changed. In addition to new uses of chemotherapeutics and targeted agents, the possibilities of immunotherapy are also being explored. This review will describe the well-known use of vascular endothelial growth...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
